GR System definition

GR System means Depomed’s delivery system designed to be retained in the stomach for an extended period of time while that delivery system delivers the incorporated drug or drugs, as described in the Patent Rights.
View Source
GR System means DepoMed’s delivery system designed to be retained in the stomach for an extended period of time while that delivery system delivers the incorporated drug or drugs, and includes the delivery system described in the patents and patent applications listed in Schedule 1.32 and any and all improvements to that delivery system.
View Source
GR System means DepoMed’s delivery system designed to be retained in the stomach for an extended period of time while that delivery system delivers the incorporated drug or drugs, and includes the delivery system described in the patents and patent applications listed in Schedule
View Source

Examples of GR System in a sentence

  • BLI shall endeavour to indicate in any promotional and marketing materials for the Licensed Product that the Licensed Products incorporates the GR System.

  • The BMS Lawsuit may result in successful counterclaims by BMS against the Company based on an allegation that the Company has breached the terms of a letter agreement dated the 11th of July, 1996, relating to a joint research project for the production of a product consisting of formulations of metformin hydrochloride incorporated in the Company's GR System, or alleging that United States Patent No. 6,340,475 is invalid.

  • At the conclusion of Stage 1 of the Research Plan, and prior to commencing work on Stage 2, the parties shall meet to negotiate the basic terms of a definitive Development Agreement and License, which will provide, inter alia, for an exclusive worldwide license to PRI and mutually agreeable development payments, milestone payments and/or royalties payable to DepoMed on net sales by PRI, its affiliates and sublicensees of any such product containing formulations of [* *] utilizing the GR System.

  • The BMS Lawsuit may result in successful counterclaims by BMS against DepoMed based on an allegation that DepoMed has breached the terms of a letter agreement dated the 11th of July, 1996, relating to a joint research project for the production of a product consisting of formulations of metformin hydrochloride incorporated in the DepoMed GR System, or alleging that United States Patent No. 6,340,475 is invalid.

  • All rights, title and interest to inventions, discoveries or improvements first conceived or made as a result of the performance of the Research Plan ("Inventions") that relate solely to the GR System, shall belong to DepoMed.